You just read:

Immune Pharmaceuticals' Oncology Subsidiary, Cytovia Inc. Provides Update to Proposed Pint Pharma Transaction: Substantial Agreement Reached on Material Terms of the Licensing and Commercialization of Ceplene® in Latin America

News provided by

Immune Pharmaceuticals Inc.

Jun 29, 2017, 08:30 ET